Pure Mucinous Carcinoma of the Breast: A review of current literature regarding diagnostic performance and genomic testing
Abstract
Full Text:
PDFReferences
References
Moschetta M, Telegrafo M, Carluccio D, Jablonska J, Rella L, Serio G, et al. Comparison between fine needle aspiration cytology (FNAC) and core needle biopsy (CNB) in the diagnosis of breast lesions. Il Giornale di chirurgia. 2014;35(7-8):171.
Cao A-Y, He M, Liu Z-B, Di G-H, Wu J, Lu J-S, et al. Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China. Annals of surgical oncology. 2012;19(9):3019-27.
Bae SY, Choi M-Y, Cho DH, Lee JE, Nam SJ, Yang J-H. Mucinous carcinoma of the breast in comparison with invasive ductal carcinoma: clinicopathologic characteristics and prognosis. Journal of breast cancer. 2011;14(4):308-13.
Di Saverio S, Gutierrez J, Avisar E. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma. Breast cancer research and treatment. 2008;111(3):541-7.
Diab SG, Clark GM, Osborne CK, Libby A, Allred DC, Elledge RM. Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas. Journal of clinical oncology. 1999;17(5):1442-.
Komaki K, Sakamoto G, Sugano H, Morimoto T, Monden Y. Mucinous carcinoma of the breast in Japan. Cancer. 1988;61:989-96.
André S, Cunha F, Soares J, Bernardo M, Sousa E, Meneses J, et al. Mucinous carcinoma of the breast: a pathologic study of 82 cases. Journal of surgical oncology. 1995;58(3):162-7.
Lacroix‐Triki M, Suarez PH, MacKay A, Lambros MB, Natrajan R, Savage K, et al. Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type. The Journal of pathology. 2010;222(3):282-98.
Lei L, Yu X, Chen B, Chen Z, Wang X. Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study. PloS one. 2016;11(5):e0155132.
Sas-Korczyńska B, Mituś J, Stelmach A, Ryś J, Majczyk A. Mucinous breast cancer–clinical characteristics and treatment results in patients treated at the Oncology Centre in Kraków between 1952 and 2002. Contemp Oncol (Pozn). 2014;18(2):120-3.
Cyrta J, Andreiuolo F, Azoulay S, Balleyguier C, Bourgier C, Mazouni C, et al. Pure and mixed mucinous carcinoma of the breast: fine needle aspiration cytology findings and review of the literature. Cytopathology. 2013;24(6):377-84.
Skotnicki P, Sas‐Korczynska B, Strzepek L, Jakubowicz J, Blecharz P, Reinfuss M, et al. Pure and mixed mucinous carcinoma of the breast: a comparison of clinical outcomes and treatment results. The breast journal. 2016;22(5):529-34.
Rosen PP, Lesser ML, Kinne DW. Breast carcinoma at the extremes of age: a comparison of patients younger than 35 years and older than 75 years. Journal of surgical oncology. 1985;28(2):90-6.
Anderson WF, Chu KC, Chang S, Sherman ME. Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma. Cancer Epidemiology and Prevention Biomarkers. 2004;13(7):1128-35.
Park S, Koo J, Kim J-H, Yang WI, Park B-W, Lee KS. Clinicopathological characteristics of mucinous carcinoma of the breast in Korea: comparison with invasive ductal carcinoma-not otherwise specified. Journal of Korean medical science. 2010;25(3):361-8.
Yang M, Li X, Pang C-H, Huang L-P. Pure mucinous breast carcinoma: a favorable subtype. Breast Care. 2013;8(1):56-9.
Dhillon R, Depree P, Metcalf C, Wylie E. Screen-detected mucinous breast carcinoma: potential for delayed diagnosis. Clinical radiology. 2006;61(5):423-30.
Capella C, Eusebi V, Mann B, Azzopardi J. Endocrine differentiation in mucoid carcinoma of the breast. Histopathology. 1980;4(6):613-30.
Kashiwagi S, Onoda N, Asano Y, Noda S, Kawajiri H, Takashima T, et al. Clinical significance of the sub-classification of 71 cases mucinous breast carcinoma. Springerplus. 2013;2(1):481.
Laucirica R, Bentz JS, Khalbuss WE, Clayton AC, Souers RJ, Moriarty AT. Performance characteristics of mucinous (colloid) carcinoma of the breast in fine-needle aspirates: observations from the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytopathology. Archives of pathology & laboratory medicine. 2011;135(12):1533-8.
Kline TS, Kannan V, Kline IK. Appraisal and cytomorphologic analysis of common carcinomas of the breast. Diagnostic cytopathology. 1985;1(3):188-93.
Wang M, He X, Chang Y, Sun G, Thabane L. A sensitivity and specificity comparison of fine needle aspiration cytology and core needle biopsy in evaluation of suspicious breast lesions: A systematic review and meta-analysis. The Breast. 2017;31:157-66.
Willems SM, Van Deurzen C, Van Diest P. Diagnosis of breast lesions: fine-needle aspiration cytology or core needle biopsy? A review. Journal of clinical pathology. 2012;65(4):287-92.
Kontzoglou K, Moulakakis KG, Alexiou D, Safioleas MC, Nikiteas N, Giahnaki A-E, et al. The role of liquid-based cytology in the investigation of colorectal lesions: a cytohistopathological correlation and evaluation of diagnostic accuracy. Langenbeck's Archives of Surgery. 2007;392(2):189-95.
Lee KR, Papillo JL, St John T, Eyerer GJ. Evaluation of the ThinPrep processor for fine needle aspiration specimens. Acta cytologica. 1996;40(5):895-9.
Ariga R, Bloom K, Reddy VB, Kluskens L, Francescatti D, Dowlat K, et al. Fine-needle aspiration of clinically suspicious palpable breast masses with histopathologic correlation. The American journal of surgery. 2002;184(5):410-3.
Veneti S, Daskalopoulou D, Zervoudis S, Papasotiriou E, Ioannidou-Mouzaka L. Liquid-based cytology in breast fine needle aspiration. Acta cytologica. 2003;47(2):188-92.
Leung CS, Chiu B, Bell V. Comparison of ThinPrep and conventional preparations: nongynecologic cytology evaluation. Diagnostic cytopathology. 1997;16(4):368-71.
Michael CW, Hunter B. Interpretation of fine-needle aspirates processed by the Thin Prep technique: Cytologic artifacts and diagnostic pitfalls. Presented in part at the 46th Annual scientific Meeting of the American Society of Cytopathology, Nashville, Tennessee, November 3–7, 1998. 2000.
Gupta R, McHutchison A, Simpson J, Dowle C. Value of fine needle aspiration cytology of the breast, with an emphasis on the cytodiagnosis of colloid carcinoma. Acta cytologica. 1990;35(6):703-9.
Stanley MW, Tani EM, Skoog L. Mucinous breast carcinoma and mixed mucinous‐infiltrating ductal carcinoma: A comparative cytologic study. Diagnostic cytopathology. 1989;5(2):134-8.
Duane G, Kanter M, Branigan T, Chang C. A morphologic and morphometric study of cells from colloid carcinoma of the breast obtained by fine needle aspiration. Distinction from other breast lesions. Acta cytologica. 1986;31(6):742-50.
Ventura K, Cangiarella J, Lee I, Moreira A, Waisman J, Simsir A. Aspiration biopsy of mammary lesions with abundant extracellular mucinous material. American journal of clinical pathology. 2003;120(2):194-202.
Ross JS, Gay LM, Nozad S, Wang K, Ali SM, Boguniewicz A, et al. Clinically advanced and metastatic pure mucinous carcinoma of the breast: a comprehensive genomic profiling study. Breast cancer research and treatment. 2016;155(2):405-13.
Vo T, Xing Y, Meric-Bernstam F, Mirza N, Vlastos G, Symmans WF, et al. Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy. The American Journal of Surgery. 2007;194(4):527-31.
Avisar E, Khan MA, Axelrod D, Oza K. Pure mucinous carcinoma of the breast: a clinicopathologic correlation study. Annals of surgical oncology. 1998;5(5):447-51.
Norris HJ, Taylor HB. Prognosis of mucinous (gelatinous) carcinoma of the breast. Cancer. 1965;18(7):879-85.
Fentiman I, Millis R, Smith P, Ellul J, Lampejo O. Mucoid breast carcinomas: histology and prognosis. British journal of cancer. 1997;75(7):1061.
Rasmussen BB, Rose C, Christensen I. Prognostic factors in primary mucinous breast carcinoma. American journal of clinical pathology. 1987;87(2):155-60.
Toikkanen S, Eerola E, Ekfors T. Pure and mixed mucinous breast carcinomas: DNA stemline and prognosis. Journal of clinical pathology. 1988;41(3):300-3.
Dahlstrom JE, Rakha EA, Lakhani SR, Schnitt SJ. Current topics in breast pathology: expert perspectives. Elsevier; 2017.
Ross JS, Gay LM. Comprehensive genomic sequencing and the molecular profiles of clinically advanced breast cancer. Pathology. 2016.
Fujii H, Anbazhagan R, Bornman DM, Garrett ES, Perlman E, Gabrielson E. Mucinous cancers have fewer genomic alterations than more common classes of breast cancer. Breast cancer research and treatment. 2002;76(3):255-60.
Lacroix-Triki M, Lambros MB, Geyer FC, Suarez PH, Reis-Filho JS, Weigelt B. Absence of microsatellite instability in mucinous carcinomas of the breast. Int J Clin Exp Pathol. 2010;4(1):22-31.
May M, Mosto J, Vazquez PM, Gonzalez P, Rojas P, Gass H, et al. Nuclear staining of fgfr-2/stat-5 and runx-2 in mucinous breast cancer. Experimental and molecular pathology. 2016;100(1):39-44.
Kehr EL, Jorns JM, Ang D, Warrick A, Neff T, Degnin M, et al. Mucinous breast carcinomas lack PIK3CA and AKT1 mutations. Human pathology. 2012;43(12):2207-12.
Horlings HM, Weigelt B, Anderson EM, Lambros MB, Mackay A, Natrajan R, et al. Genomic profiling of histological special types of breast cancer. Breast cancer research and treatment. 2013;142(2):257-69.
Campbell IG, Russell SE, Choong DY, Montgomery KG, Ciavarella ML, Hooi CS, et al. Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer research. 2004;64(21):7678-81.
Maruyama N, Miyoshi Y, Taguchi T, Tamaki Y, Monden M, Noguchi S. Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women. Clinical cancer research. 2007;13(2):408-14.
Zhou F, Li S, Meng H-M, Qi L-Q, Gu L. MicroRNA and histopathological characterization of pure mucinous breast carcinoma. Cancer biology & medicine. 2013;10(1):22-7.
DOI: http://dx.doi.org/10.18103/imr.v3i6.454
Refbacks
- There are currently no refbacks.